134 related articles for article (PubMed ID: 10207306)
1. The IKs channel: coassembly of IsK (minK) and KvLQT1 proteins.
Suessbrich H; Busch AE
Rev Physiol Biochem Pharmacol; 1999; 137():191-226. PubMed ID: 10207306
[No Abstract] [Full Text] [Related]
2. MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel.
Wang W; Xia J; Kass RS
J Biol Chem; 1998 Dec; 273(51):34069-74. PubMed ID: 9852064
[TBL] [Abstract][Full Text] [Related]
3. Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome.
Sesti F; Goldstein SA
J Gen Physiol; 1998 Dec; 112(6):651-63. PubMed ID: 9834138
[TBL] [Abstract][Full Text] [Related]
4. Functional coupling of human beta 3-adrenoreceptors to the KvLQT1/MinK potassium channel.
Kathöfer S; Zhang W; Karle C; Thomas D; Schoels W; Kiehn J
J Biol Chem; 2000 Sep; 275(35):26743-7. PubMed ID: 10823835
[TBL] [Abstract][Full Text] [Related]
5. Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits.
Franqueza L; Lin M; Shen J; Splawski I; Keating MT; Sanguinetti MC
J Biol Chem; 1999 Jul; 274(30):21063-70. PubMed ID: 10409658
[TBL] [Abstract][Full Text] [Related]
6. The role of the IsK protein in the specific pharmacological properties of the IKs channel complex.
Busch AE; Busch GL; Ford E; Suessbrich H; Lang HJ; Greger R; Kunzelmann K; Attali B; Stühmer W
Br J Pharmacol; 1997 Sep; 122(2):187-9. PubMed ID: 9313924
[TBL] [Abstract][Full Text] [Related]
7. An LQT mutant minK alters KvLQT1 trafficking.
Krumerman A; Gao X; Bian JS; Melman YF; Kagan A; McDonald TV
Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1453-63. PubMed ID: 14761891
[TBL] [Abstract][Full Text] [Related]
8. Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1.
Sanguinetti MC
J Cardiovasc Electrophysiol; 2000 Jun; 11(6):710-2. PubMed ID: 10868746
[TBL] [Abstract][Full Text] [Related]
9. KCNE regulation of KvLQT1 channels: structure-function correlates.
Melman YF; Krummerman A; McDonald TV
Trends Cardiovasc Med; 2002 May; 12(4):182-7. PubMed ID: 12069759
[TBL] [Abstract][Full Text] [Related]
10. Single-channel properties of IKs potassium channels.
Yang Y; Sigworth FJ
J Gen Physiol; 1998 Dec; 112(6):665-78. PubMed ID: 9834139
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cardiac delayed rectifier K+ currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N in neonatal mouse hearts.
Ohyama H; Kajita H; Omori K; Takumi T; Hiramoto N; Iwasaka T; Matsuda H
Pflugers Arch; 2001 Jun; 442(3):329-35. PubMed ID: 11484762
[TBL] [Abstract][Full Text] [Related]
12. Human beta(3)-adrenoreceptors couple to KvLQT1/MinK potassium channels in Xenopus oocytes via protein kinase C phosphorylation of the KvLQT1 protein.
Kathöfer S; Röckl K; Zhang W; Thomas D; Katus H; Kiehn J; Kreye V; Schoels W; Karle C
Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):119-26. PubMed ID: 12879210
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity.
Romey G; Attali B; Chouabe C; Abitbol I; Guillemare E; Barhanin J; Lazdunski M
J Biol Chem; 1997 Jul; 272(27):16713-6. PubMed ID: 9201970
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk.
Chouabe C; Neyroud N; Richard P; Denjoy I; Hainque B; Romey G; Drici MD; Guicheney P; Barhanin J
Cardiovasc Res; 2000 Mar; 45(4):971-80. PubMed ID: 10728423
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits.
Tristani-Firouzi M; Sanguinetti MC
J Physiol; 1998 Jul; 510 ( Pt 1)(Pt 1):37-45. PubMed ID: 9625865
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of the arrhythmogenic G306R KvLQT1 K+ channel mutant probed by viral gene transfer in cardiomyocytes.
Li RA; Miake J; Hoppe UC; Johns DC; Marbán E; Nuss HB
J Physiol; 2001 May; 533(Pt 1):127-33. PubMed ID: 11351021
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation.
Demolombe S; Lande G; Charpentier F; van Roon MA; van den Hoff MJ; Toumaniantz G; Baro I; Guihard G; Le Berre N; Corbier A; de Bakker J; Opthof T; Wilde A; Moorman AF; Escande D
Cardiovasc Res; 2001 May; 50(2):314-27. PubMed ID: 11334835
[TBL] [Abstract][Full Text] [Related]
18. Congenital and acquired long QT syndrome.
Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
[No Abstract] [Full Text] [Related]
19. Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias.
Chouabe C; Neyroud N; Guicheney P; Lazdunski M; Romey G; Barhanin J
EMBO J; 1997 Sep; 16(17):5472-9. PubMed ID: 9312006
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of KvLQT1 and its regulator IsK in mouse epithelia.
Demolombe S; Franco D; de Boer P; Kuperschmidt S; Roden D; Pereon Y; Jarry A; Moorman AF; Escande D
Am J Physiol Cell Physiol; 2001 Feb; 280(2):C359-72. PubMed ID: 11208532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
